How we work

We constantly push ourselves in the pursuit of better – better solutions, better processes and better ways of working that help our clients navigate complexity and make better decisions with greater confidence

The Journey

We recognise that the journey is often as important as the destination. We work like an extension of your team so your overall journey with us feels better

The Journey

Our Values

Our culture is founded on a strong set of values that guide how we work with each other and our clients. We are a PASSIONATE team who believe in COLLABORATIVE SPIRIT and a CAN-DO attitude. We build BOLD solutions and make insightful recommendations because we dig deeper and remain CONSTANTLY CURIOUS, to provide positive challenge and FRESH THINKING

Our Values

Solving unique problems

Whether we are supporting you on your journey, or delivering specialist expertise, we are helping you make important choices

Job openings

With a global perspective

We work with 24 of the top 25 pharmaceutical companies as well as 100s of Biotechs globally from our offices in the US and Europe

Our locations

Teams of experts

We are expert navigators helping guide our clients to more successful outcomes

Our People

Expert Navigation

Explore case studies that bring to life how we’ve uncovered hidden insights, explored scientific options and helped make difficult strategic choices

Case studies
Proliferation of Novel Cell Type Platforms in the Oncology Competitive Landscape-Part II
Proliferation of Novel Cell Type Platforms in the Oncology Competitive Landscape-Part II
Perhaps more so than any other modality to date, cancer cell therapies have captured the imaginations and wherewithal of industry, investor, and oncologist communities alike.
Differentiating in oncology.  Are you being clear?
Differentiating in oncology. Are you being clear?
Oncology markets continue to rapidly evolve and grow.  New entrants with novel mechanisms of action and a wealth of new data mean patient outcome goals are more varied and treatment options more complex.
Detour or new direction? Future-proofing patient journeys
Detour or new direction? Future-proofing patient journeys
There is much talk of the old and new normal, but the reality of the future will be a blend of the two, and the patients’ journey with their disease will have a different shape going forward.
Vaccine Hesitancy: Using Behavioural Science to increase public acceptance of a Covid-19 vaccine
Vaccine Hesitancy: Using Behavioural Science to increase public acceptance of a Covid-19 vaccine
A rising tone of optimism is evident as we approach the end of 2020, with at least three known effective vaccines awaiting approval, plus others on the horizon pending the results of Phase III clinical trials.